
Ask a doctor about a prescription for ETORICOXIB TEVA-RATIOPHARM 30 mg FILM-COATED TABLETS
Package Leaflet:Information for the User
Etoricoxib Teva-ratiopharm 30 mg film-coated tablets EFG
Etoricoxib Teva-ratiopharm 60 mg film-coated tablets EFG
Etoricoxib Teva-ratiopharm 90 mg film-coated tablets EFG
Etoricoxib Teva-ratiopharm 120 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.Keep this leaflet. You may need to read it again.If you have any further questions, ask your doctor or pharmacist.
Contents of the pack
What is Etoricoxib Teva-ratiopharm?
What is Etoricoxib Teva-ratiopharm used for?
What is osteoarthritis?
Osteoarthritis is a disease of the joints. It leads to the gradual breakdown of the cartilage that cushions the ends of the bones. This causes swelling (inflammation), pain, sensitivity, stiffness, and disability.
What is rheumatoid arthritis?
Rheumatoid arthritis is a long-term inflammatory disease of the joints. It causes pain, stiffness, swelling, and progressive loss of movement in the affected joints. It also causes inflammation in other areas of the body.
What is gout?
Gout is a disease of sudden and recurring attacks of very painful and red swelling of the joints. It is caused by deposits of mineral crystals in the joint.
What is ankylosing spondylitis?
Ankylosing spondylitis is an inflammatory disease of the spine and long joints.
Do not take Etoricoxib Teva-ratiopharm:
Etoricoxib may slightly increase your risk of heart attack and stroke, and therefore should not be used in those patients who have already had heart or stroke problems.
If you think you are at risk of any of these conditions, do not take the tablets until you have spoken to your doctor.
Warnings and precautions
Consult your doctor or pharmacist before starting Etoricoxib Teva-ratiopharm if:
If you are not sure if any of the above applies to you, talk to your doctor before taking Etoricoxib Teva-ratiopharm to check if this medicine is suitable for you.
Etoricoxib Teva-ratiopharm works just as well in adult and elderly patients. If you are over 65 years of age, your doctor will want to keep a close check on you. No dose adjustment is necessary for patients over 65 years of age.
Children and adolescents
Do not give this medicine to children and adolescents under 16 years of age.
Taking Etoricoxib Teva-ratiopharm with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
In particular, if you are taking any of the following medicines, your doctor may want to monitor you to check that your medicines are working adequately once you start taking Etoricoxib Teva-ratiopharm:
Pregnancy, breast-feeding, and fertility
Pregnancy
Etoricoxib Teva-ratiopharm should not be taken during pregnancy. Do not take the tablets if you are pregnant, think you may be pregnant, or plan to become pregnant. If you become pregnant, stop taking the tablets and consult your doctor. Consult your doctor if you have any doubts or need more information.
Breast-feeding
It is not known if etoricoxib is excreted in human milk. If you are breast-feeding or plan to breast-feed, consult your doctor before taking Etoricoxib Teva-ratiopharm. If you are using Etoricoxib Teva-ratiopharm, do not breast-feed.
Fertility
Etoricoxib Teva-ratiopharm is not recommended for use in women who are trying to become pregnant.
Driving and using machines
In some patients taking Etoricoxib Teva-ratiopharm, dizziness and somnolence have been reported.
Do not drive if you experience dizziness or somnolence.
Do not use tools or machines if you experience dizziness or somnolence.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, check with your doctor or pharmacist.
There are different doses available for this medicine, and depending on your disease, your doctor will prescribe the tablet with the dose that is right for you.
The recommended dose is:
Osteoarthritis
The recommended dose is 30 mg once daily, increased to a maximum of 60 mg once daily if needed.
Rheumatoid arthritis
The recommended dose is 60 mg once daily, increased to a maximum of 90 mg once daily if needed.
Ankylosing spondylitis
The recommended dose is 60 mg once daily, increased to a maximum of 90 mg once daily if needed.
Acute pain conditions
Etoricoxib should only be used for the period of acute pain.
Gout
The recommended dose is 120 mg once daily, which should only be used during the period of acute pain, limited to a maximum of 8 days of treatment.
Postoperative dental pain
The recommended dose is 90 mg once daily, limited to a maximum of 3 days of treatment.
Patients with liver problems
Do not take more than the recommended dose for your disease. Your doctor will want to discuss your treatment from time to time. It is important that you use the lowest dose that controls your pain and you should not take Etoricoxib Teva-ratiopharm for longer than necessary. This is because the risk of heart attacks and strokes might increase after prolonged treatment, especially with high doses.
Use in children and adolescents
Children or adolescents under 16 years of age should not take Etoricoxib Teva-ratiopharm.
Elderly patients
No dose adjustment is necessary for elderly patients. As with other medicines, caution should be exercised in elderly patients.
Method of administration
Etoricoxib Teva-ratiopharm is administered orally.
Take the tablets once daily. Etoricoxib Teva-ratiopharm can be taken with or without food.
If you take more Etoricoxib Teva-ratiopharm than you should
Never take more tablets than your doctor recommends. If you take too many tablets of Etoricoxib Teva-ratiopharm, seek medical attention immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Etoricoxib Teva-ratiopharm
It is important that you take Etoricoxib Teva-ratiopharm as your doctor has instructed. If you forget a dose, just resume your normal schedule the next day.
Do not take a double dose to make up for forgotten doses.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you develop any of these signs, stop taking Etoricoxib Teva-ratiopharm and talk to your doctor immediately (see section 2 What you need to know before you take Etoricoxib Teva-ratiopharm):
The following side effects may occur during treatment with Etoricoxib Teva-ratiopharm:
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Agency's Pharmacovigilance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after CAD. The expiry date is the last day of the month indicated.
Store in the original package to protect from light.
Do not use this medicine if you notice visible signs of deterioration.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and unused medicine. This will help protect the environment.
Composition of Etoricoxib Teva-ratiopharm
The active substance is etoricoxib.
Each film-coated tablet contains 30 mg of etoricoxib.
Each film-coated tablet contains 60 mg of etoricoxib.
Each film-coated tablet contains 90 mg of etoricoxib.
Each film-coated tablet contains 120 mg of etoricoxib.
Core: hydrogenated calcium phosphate (anhydrous), crospovidone (type A), microcrystalline cellulose, povidone K25, magnesium stearate.
Tablet coating: hypromellose, hydroxypropylcellulose, talc, medium-chain triglycerides, titanium dioxide (E171), microcrystalline cellulose (30 mg), red iron oxide (30 mg) (E172), aluminum lake indigo carmine (30, 60, and 120 mg) (E132), aluminum lake brilliant blue (60 and 120 mg) (E133), yellow iron oxide (60 and 120 mg) (E172), black iron oxide (60 and 120 mg) (E172).
Appearance of the Product and Package Contents
30 mg film-coated tablet, blue, round, biconvex, marked with "30" on one side and smooth on the other.
60 mg film-coated tablet, dark green, round, biconvex, marked with "60" on one side and smooth on the other.
90 mg film-coated tablet, white, round, biconvex, marked with "90" on one side and smooth on the other.
120 mg film-coated tablet, light green, round, biconvex, marked with "120" on one side and smooth on the other.
Package sizes:
30 mg
OPA/Alu/PVC - Aluminum blister packs containing 7, 28, 28x1, 98 film-coated tablets.
60 mg
OPA/Alu/PVC - Aluminum blister packs containing 7, 20, 28, 28x1, 50, 98, 100 film-coated tablets.
90 mg
OPA/Alu/PVC - Aluminum blister packs containing 7, 7x1, 20, 28, 28x1, 50, 98, 100 film-coated tablets.
120 mg
OPA/Alu/PVC - Aluminum blister packs containing 7, 7x1, 14, 20, 28, 28x1, 98, 100 film-coated tablets.
Not all pack sizes may be marketed.
Marketing Authorization Holder
Teva Pharma, S.L.U.
C/ Anabel Segura, 11. Edificio Albatros B, 1ª planta.
28108 Alcobendas, Madrid
Spain
Manufacturer
Teva Gyógyszergyár Zrt.
Debrecen, Pallagi út 13,
H-4042
Hungary
or
Teva Nederland BV
Swensweg 5, Haarlem
2031 GA
Netherlands
or
Teva Czech Industries s.r.o.
Ostravska 29, c.p. 305, Opava-Komarov
74770
Czech Republic
or
Teva Operations Poland Sp. z.o.o
ul. Mogilska 80,
Krakow, 31-546
Poland
or
Teva Pharma, S.L.U.
C/C, n. 4, Polígono Industrial Malpica,
Zaragoza, 50016
Spain
or
Merckle GmbH
Ludwig-Merckle-Straße 3,
Blaubeuren, 89143
Germany
or
PLIVA Hrvatska d.o.o. (PLIVA Croatia Ltd.)
Prilaz baruna Filipovica 25, Zagreb
10000
Croatia
This medicine is authorized in the Member States of the European Economic Area under the following names:
Germany:Etoricoxib-ratiopharm 30 mg, 60 mg, 90 mg & 120 mg Filmtabletten
Finland:Etoricoxib ratiopharm 30 mg, 60 mg, 90 mg & 120 mg tabletti, kalvopäällysteinen
Iceland:Etoricoxib ratiopharm 30 mg, 60 mg, 90 mg & 120 mg filmuhúðaðar töflur
Luxembourg:Etoricoxib-ratiopharm 30 mg, 60 mg, 90 mg & 120 mg Filmtabletten
Portugal:Etoricoxib ratiopharm
Spain:Etoricoxib Teva-ratiopharm 30 mg, 60 mg, 90 mg y 120 mg comprimidos recubiertos con película EFG
Date of the last revision of thisleaflet:September 2016
Other sources of information
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)
You can access detailed and up-to-date information about this medicine by scanning the QR code included in the packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/80961/P_80961.html
QR code + URL
The average price of ETORICOXIB TEVA-RATIOPHARM 30 mg FILM-COATED TABLETS in December, 2025 is around 5.37 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ETORICOXIB TEVA-RATIOPHARM 30 mg FILM-COATED TABLETS – subject to medical assessment and local rules.